← Back to Patent Explorer
US4434160A Expired / Lapsed US ⏱️ 0.0 years remaining

Nutrient solution for complete parenteral feeding and for increased energy production

Assignee: Leopold and Co Chem Pharm Fabrik GmbH
•
Filing: 1981-07-07
•
Granted: 1984-02-28
•
Expires: 2001-07-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A nutrient solution for complete parenteral feeding and for increased energy production, for administration to patients in the post-aggression phase, which contains, in aqueous solution, per 25 parts by weight of an aminoacid mixture, at most 50 parts by weight of glucose or glucose substitutes or both, and 0.8-1.2 parts by weight of L-carnitine in the form of one of its salts. Preferably, the solution also contains electrolytes.

Inventors

  • 👤 Stojan Jeretin
  • 👤 Karl Groke
  • 👤 Horst E. Musil

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 14:51
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/01; A61K31/00; A61K31/185; A61K31/205; A61P; A61P3/00

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 110 words
An aqueous fat-free composition for the parenteral feeding and for the treatment of patients in the post-aggression phase in order to ensure an adequate supply of amino-acids consisting essentially of the following mixture: (a) glucose or glucose substitutes selected from the group consisting of fructose and sugar alcohols or a mixture of glucose and said glucose substitutes in at least an amount exceeding the normal body's demand and up to 50 parts by weight; (b) 0.8-1.2 parts by weight of L-carnitine as an inner salt or as a pharmaceutically tolerated acid addition salt; and (c) 25 parts by weight of an amino acid mixture composed of the following amino acids:
Claim 2
Dependent Claim 110 words
An aqueous fat-free composition for the parenteral feeding and for the treatment of patients in the post-aggression phase in order to ensure an adequate supply of amino-acids consisting essentially of the following mixture: (a) glucose or glucose substitutes selected from the group consisting of fructose and sugar alcohols or a mixture of glucose and said glucose substitutes in at least an amount exceeding the normal body's demand and up to 50 parts by weight; (b) 0.8-1.2 parts by weight of L-carnitine as an inner salt or as a pharmaceutically tolerated acid addition salt; and (c) 25 parts by weight of an amino acid mixture composed of the following amino acids:
Claim 3
Dependent Claim 134 words
8-1.05 parts by weight of L-isoleucine 1.4-1.5 parts by weight of L-leucine 1.4-1.65 parts by weight of L-lysine 0.5-1.2 parts by weight of L-methionine 1.25-1.4 parts by weight of L-phenylalanine 0.7-1.05 parts by weight of L-threonine 0.35-0.375 parts by weight of L-tryptophane 1.0-1.5 parts by weight of L-valine 2.0-2.8 parts by weight of L-arginine 1.0-1.5 parts by weight of L-histidine 3.5-4.0 parts by weight of L-alanine 0.35-0.55 parts by weight of L-aspartic acid 0.1 part by weight of L-cysteine 2.0-2.25 parts by weight of L-glutamic acid 1.5-2.3 parts by weight of glycine 0-0.625 part by weight of ornithine 2.2-2.8 parts by weight of L-proline 1.1-1.4 parts by weight of L-serine 0-1.5 parts by weight of L-tyrosine, the amino acids L-tyrosine and L-cysteine being present in the solution in the form of their acyl derivatives.
Claim 4
Dependent Claim 134 words
8-1.05 parts by weight of L-isoleucine 1.4-1.5 parts by weight of L-leucine 1.4-1.65 parts by weight of L-lysine 0.5-1.2 parts by weight of L-methionine 1.25-1.4 parts by weight of L-phenylalanine 0.7-1.05 parts by weight of L-threonine 0.35-0.375 parts by weight of L-tryptophane 1.0-1.5 parts by weight of L-valine 2.0-2.8 parts by weight of L-arginine 1.0-1.5 parts by weight of L-histidine 3.5-4.0 parts by weight of L-alanine 0.35-0.55 parts by weight of L-aspartic acid 0.1 part by weight of L-cysteine 2.0-2.25 parts by weight of L-glutamic acid 1.5-2.3 parts by weight of glycine 0-0.625 part by weight of ornithine 2.2-2.8 parts by weight of L-proline 1.1-1.4 parts by weight of L-serine 0-1.5 parts by weight of L-tyrosine, the amino acids L-tyrosine and L-cysteine being present in the solution in the form of their acyl derivatives.
Claim 5
Dependent Claim 48 words
A composition according to claim 1 which additionally contains electrolytes selected from the group consisting of Na + , Ca ++ , Mg ++ , Zn ++ , K + , chloride-ions and acetate-ions in an amount sufficient to maintain the homeostasis and acid-base equilibrium in the body.
Claim 6
Dependent Claim 25 words
A composition according to claim 2, in which the amount of electrolyte is about 2.5 parts by weight per 25 parts by weight of aminoacids.
Claim 7
Dependent Claim 21 words
A composition according to claim 1, in which the concentration of the amino acid mixture is 3 to 10% per weight.
Claim 8
Dependent Claim 53 words
A process for complete parenteral feeding and treatment of a patient in the post aggression phase in order to ensure adequate supply with amino acids, comprising intravenously infusing said patient with the aqueous composition according to claim 1 in which an amount corresponding to 100 g of the amino acid mixture per day.
Claim 9
Dependent Claim 54 words
A process according to claim 5, in which the aqueous composition contains additionally electrolytes selected from the group consisting of Na + , Ca ++ , Mg ++ , Zn ++ , K + , chloride ions and acetate ions in an amount sufficient to maintain the homeostasis and acid-base equilibrium in the body.
Claim 10
Dependent Claim 34 words
A process according to claim 6, in which the amount of the electrolytes present in the aqueous composition is about 2.5 parts by weight per B 25 parts by weight of the amino acids.

References Cited (Backward Citations)

GB1435916A Cited
US3810994A Cited
GB2021410B Cited
US4320145A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-02-27 1987-08-29 1988-02-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-02-27 1991-08-29 1992-02-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-02-27 1995-08-29 1996-02-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag